Boston, MA, United States of America

Kenneth Oliveira

This inventor holds 2 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: Advandx, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Oliveira. Retrieved from https://idiyas.com/inventor/kenneth-oliveira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Kenneth Oliveira

Introduction

Kenneth Oliveira is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of peptide nucleic acid (PNA) probes. With a total of 2 patents to his name, Oliveira's work has the potential to impact diagnostic methods and analysis in various applications.

Latest Patents

Oliveira's latest patents focus on peptide nucleic acid (PNA) probes and probe sets. These inventions relate to methods for analyzing certain species that may be present in a sample. Additionally, his patents include the development of diagnostic kits that incorporate these PNA probes or probe sets, enhancing the capabilities of diagnostic testing.

Career Highlights

Kenneth Oliveira is currently associated with Advandx, Inc., where he continues to innovate in the field of biotechnology. His work at Advandx has allowed him to explore new methodologies and applications for PNA technology, contributing to advancements in diagnostics.

Collaborations

Throughout his career, Oliveira has collaborated with notable colleagues, including Henrik Stender and Mark J Fiandaca. These collaborations have fostered a productive environment for innovation and research, leading to the development of impactful technologies.

Conclusion

Kenneth Oliveira's contributions to the field of biotechnology through his patents and work at Advandx, Inc. highlight his role as a significant inventor. His innovations in peptide nucleic acid technology are paving the way for advancements in diagnostic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…